Finally, TRAF4 was associated with oncogenic effects in ACC (OS: n = 79, p = 0.003, Supplementary Fig. 2A), HNSC (OS: n = 501, p = 0.023, Supplementary Fig. 2B), KIRC (OS: n = 531, p = 0.005, Supplementary Fig. 2C), LIHC (OS: n = 368, p = 0.032, Supplementary Fig. 2D), and Sarcoma (SARC) (OS: n = 260, p = 0.036, Supplementary Fig. 2E). This evidence concerns the gene TRAF4 and sarcoma.